FDAnews
www.fdanews.com/articles/81608-aerie-pharmaceuticals-announces-21-million-series-a-financing

AERIE PHARMACEUTICALS ANNOUNCES $21 MILLION SERIES A FINANCING

October 12, 2005

Aerie Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $21 million Series A financing. The syndicate was co-led by Alta Partners and Texas Pacific Group Ventures. In connection with the financing, Geoff Duyk, MD, Ph.D., a managing director at TPG Ventures and David Mack, Ph.D., a director at Alta Partners will join Aerie's board of directors.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1077229XSL_NEWSML_TO_NEWSML_WEB.xml)